Gregory Kricorian

6PUBLICATIONS
23CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of diseaseMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 27, 2025
ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis.

Emma Guttman-Yassky, Eric Simpson, Robert Bissonnette

|Feb 10, 2024
Correction to: OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic Target.

Michael Croft, Ehsanollah Esfandiari, Camilla Chong

|Jan 18, 2024
OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic Target.

Michael Croft, Ehsanollah Esfandiari, Camilla Chong

|Nov 18, 2020
Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission.

Jeffrey R Curtis, Paul Emery, Elaine Karis

Pageof 1